Detailed NET Patient Survey results from US

pancreasiPadAppImg 3 The detailed manuscript on titled “Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results from a Large Patient Survey in the United States,” is now available for viewing.  

The aim of this survey was to examine the experience of patients with NETs to raise awareness of the NET-related burden and identify unmet needs.  This manuscript reports on data from patients in the United States. 

Check it out here:      Patient Survey – Pancreas Journal

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

$3 million boost for neuroendocrine cancer research: PLANETARI launches nationally

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

NECA partners with Oncidium ahead of World Radiotheranostics Day 2026

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.